Global Patent Index - EP 3506926 A4

EP 3506926 A4 20201014 - NEUROMODULATING COMPOSITIONS AND RELATED THERAPEUTIC METHODS FOR THE TREATMENT OF INFLAMMATORY AND AUTOIMMUNE DISEASES

Title (en)

NEUROMODULATING COMPOSITIONS AND RELATED THERAPEUTIC METHODS FOR THE TREATMENT OF INFLAMMATORY AND AUTOIMMUNE DISEASES

Title (de)

NEUROMODULIERENDE ZUSAMMENSETZUNGEN UND ZUGEHÖRIGE THERAPEUTISCHE VERFAHREN ZUR BEHANDLUNG VON ENTZÜNDUNGS- UND AUTOIMMUNERKRANKUNGEN

Title (fr)

COMPOSITIONS DE NEUROMODULATION ET MÉTHODES THÉRAPEUTIQUES ASSOCIÉES POUR LE TRAITEMENT DE MALADIES INFLAMMATOIRES ET AUTO-IMMUNES

Publication

EP 3506926 A4 20201014 (EN)

Application

EP 17835144 A 20170725

Priority

  • US 201662366773 P 20160726
  • US 2017043802 W 20170725

Abstract (en)

[origin: WO2018022668A2] Described herein are methods for treating a subject having or at risk of developing cancer by administering a neuromodulating agent.

IPC 8 full level

A61K 38/17 (2006.01); A61P 25/00 (2006.01); A61P 37/02 (2006.01); A61P 37/04 (2006.01); A61P 37/06 (2006.01)

CPC (source: EP US)

A61K 31/137 (2013.01 - EP); A61K 31/4045 (2013.01 - EP); A61K 31/428 (2013.01 - EP); A61K 31/439 (2013.01 - EP); A61K 31/445 (2013.01 - EP); A61K 31/473 (2013.01 - EP); A61K 31/48 (2013.01 - EP); A61K 31/506 (2013.01 - EP); A61K 38/095 (2018.12 - EP); A61K 38/16 (2013.01 - EP); A61K 38/1787 (2013.01 - US); A61K 38/18 (2013.01 - EP); A61K 38/19 (2013.01 - EP); A61K 38/225 (2013.01 - EP); A61K 38/2271 (2013.01 - EP US); A61K 38/33 (2013.01 - EP); A61K 45/06 (2013.01 - EP); A61P 25/00 (2017.12 - EP); A61P 33/02 (2017.12 - US); A61P 35/00 (2017.12 - EP); A61P 37/02 (2017.12 - EP); C07K 16/22 (2013.01 - EP); G01N 33/5047 (2013.01 - US); A61K 31/445 (2013.01 - US); A61K 31/4515 (2013.01 - US); A61K 31/519 (2013.01 - US); A61K 31/7068 (2013.01 - US); A61K 38/095 (2018.12 - US); A61K 38/16 (2013.01 - US); A61K 38/17 (2013.01 - US); A61K 38/18 (2013.01 - US); A61K 38/19 (2013.01 - US); A61K 38/225 (2013.01 - US); A61K 38/33 (2013.01 - US); A61K 45/06 (2013.01 - US); A61K 2039/505 (2013.01 - EP US); A61P 25/00 (2017.12 - US); A61P 35/00 (2017.12 - US); A61P 37/02 (2017.12 - US); C07K 14/5406 (2013.01 - US); C07K 14/57545 (2013.01 - US); C07K 16/22 (2013.01 - US); C07K 16/26 (2013.01 - US); C07K 2317/76 (2013.01 - EP US)

Citation (search report)

  • [X] US 5264459 A 19931123 - CHELMICKA-SCHORR EWA E [US], et al
  • [X] US 2007112076 A1 20070517 - STEINLE JENA [US]
  • [X] US 5290815 A 19940301 - JOHNSON MALCOLM [GB], et al
  • [X] C. SZABÓ ET AL: "Isoproterenol regulates tumour necrosis factor, interleukin-10, interleukin-6 and nitric oxide production and protects against the development of vascular hyporeactivity in endotoxaemia", IMMUNOLOGY, vol. 90, no. 1, 1 January 1997 (1997-01-01), GB, pages 95 - 100, XP055698821, ISSN: 0019-2805, DOI: 10.1046/j.1365-2567.1997.00137.x
  • [X] TOMOMI HASHIMOTO ET AL: "Effect of Formoterol on Allergen-Induced Cytokine Synthesis by Atopic Asthmatics", INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY, vol. 143, no. 1, 1 January 2007 (2007-01-01), CH, pages 106 - 109, XP055698193, ISSN: 1018-2438, DOI: 10.1159/000101415
  • [A] COLBURN 1 K ET AL: "B-adrenergic Receptor Stimulation Increases anti-DNA Antibody Production in MRL/1 Pr Mice", JOURNAL OF RHEUMATOLOGY, JOURNAL OF RHEUMATOLOGY PUBLISHING COMPANY, CA, vol. 17, no. 2, 1 February 1990 (1990-02-01), pages 138 - 41, XP009520587, ISSN: 0315-162X
  • [A] G HASKO ET AL: "Isoproterenol Inhibits IL-10, TNF-alpha, and Nitric Oxide Production in RAW 264.7 Macrophages", BRAIN RESEARCH BULLETIN, vol. 45, no. 2, 20 January 1998 (1998-01-20), pages 183 - 187, XP055698204
  • See references of WO 2018022664A1

Designated contracting state (EPC)

AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

DOCDB simple family (publication)

WO 2018022668 A2 20180201; WO 2018022668 A3 20190418; EP 3490542 A1 20190605; EP 3490542 A4 20200708; EP 3490581 A2 20190605; EP 3490581 A4 20201014; EP 3506926 A1 20190710; EP 3506926 A4 20201014; US 2019240293 A1 20190808; US 2021154272 A1 20210527; US 2021177823 A1 20210617; US 2021283217 A1 20210916; WO 2018022664 A1 20180201; WO 2018022664 A8 20180426; WO 2018022666 A1 20180201

DOCDB simple family (application)

US 2017043807 W 20170725; EP 17835144 A 20170725; EP 17835145 A 20170725; EP 17835147 A 20170725; US 2017043802 W 20170725; US 2017043804 W 20170725; US 201716320321 A 20170725; US 201716320342 A 20170725; US 202017023778 A 20200917; US 202017063258 A 20201005